Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-19-064670
Filing Date
2019-11-15
Accepted
2019-11-15 13:58:27
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm1923079d1_424b5.htm 424B5 437900
2 GRAPHIC tm1923079d1_img01.jpg GRAPHIC 13882
3 GRAPHIC tm1923079d1_img02.jpg GRAPHIC 14095
  Complete submission text file 0001104659-19-064670.txt   466963
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-220942 | Film No.: 191223587
SIC: 2834 Pharmaceutical Preparations